Veraxa Biotech AG - Post de-SPAC ratios data for the quarter ended Dec 2025. These financial ratios cover 2 quarters of results from Dec 2024 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2024 | Dec2025 |
|---|---|---|
| Efficiency | ||
| Assets AverageAssets Avg. | 98.94M | |
| Invested CapitalInvested Cap. | 37.85M | -14.85M |
| Leverage & Solvency | ||
| Debt Ratio | 0.02 | 0.05 |